Osteopore Ltd (OSX) - Total Liabilities

Latest as of December 2025: AU$4.50 Million AUD ≈ $3.18 Million USD

Based on the latest financial reports, Osteopore Ltd (OSX) has total liabilities worth AU$4.50 Million AUD (≈ $3.18 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore OSX year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Osteopore Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Osteopore Ltd's total liabilities have evolved over time, based on quarterly financial data. See Osteopore Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Osteopore Ltd Competitors by Total Liabilities

The table below lists competitors of Osteopore Ltd ranked by their total liabilities.

Company Country Total Liabilities
Treatt PLC
LSE:TET
UK GBX32.65 Million
Sure-Tech Investments LP
TA:STEC
Israel ILA1.31 Million
Cynata Therapeutics Ltd
AU:CYP
Australia AU$1.22 Million
Kiplin Metals Inc
V:KIP
Canada CA$24.99K
Hexima Ltd
AU:HXL
Australia AU$40.70K
Cascadero Copper Corp
V:CCD
Canada CA$863.86K
Grosvenor Resource Corp
V:GVR
Canada CA$27.50K
Kneomedia Ltd
AU:KNM
Australia AU$4.03 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Osteopore Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Osteopore Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.85 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.21 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -2.61 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.62 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Osteopore Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Osteopore Ltd (2016–2025)

The table below shows the annual total liabilities of Osteopore Ltd from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 AU$4.50 Million
≈ $3.18 Million
+59.11%
2024-12-31 AU$2.83 Million
≈ $2.00 Million
-2.82%
2023-12-31 AU$2.91 Million
≈ $2.06 Million
+92.30%
2022-12-31 AU$1.51 Million
≈ $1.07 Million
+138.97%
2021-12-31 AU$633.40K
≈ $448.17K
-49.39%
2020-12-31 AU$1.25 Million
≈ $885.58K
-5.01%
2019-12-31 AU$1.32 Million
≈ $932.29K
+12.72%
2018-12-31 AU$1.17 Million
≈ $827.07K
-46.50%
2017-12-31 AU$2.18 Million
≈ $1.55 Million
-1.37%
2016-12-31 AU$2.22 Million
≈ $1.57 Million
--

About Osteopore Ltd

AU:OSX Australia Medical Instruments & Supplies
Market Cap
$2.17 Million
AU$3.07 Million AUD
Market Cap Rank
#29896 Global
#1744 in Australia
Share Price
AU$0.01
Change (1 day)
+11.11%
52-Week Range
AU$0.00 - AU$0.03
All Time High
AU$15.65
About

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, United Arab Emirates, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its tech… Read more